{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:18:09Z","timestamp":1648995489853},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[1977,9,1]],"date-time":"1977-09-01T00:00:00Z","timestamp":241920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1977,9]]},"DOI":"10.1007\/bf01478829","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T03:04:37Z","timestamp":1113447877000},"page":"917-919","source":"Crossref","is-referenced-by-count":3,"title":["Einflu\ufffd des Angiotensin II-Antagonisten Saralasin auf die H\ufffdmodynamik bei Patienten mit renovaskul\ufffdrer Hypertonie"],"prefix":"10.1007","volume":"55","author":[{"given":"Th.","family":"Philipp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zschiedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"35","volume":"34","author":"H.R. Brunner","year":"1974","unstructured":"Brunner, H.R., Gavras, H., Laragh, J.H., Keenan, R.: Hypertension in man. Exposure of the renin and sodium components using angiotensin II blockade. Circ. Res., Suppl. I zu Bd.34 u.35, 35 (1974)","journal-title":"Circ. Res."},{"key":"CR2","first-page":"743","volume":"45","author":"A. Distler","year":"1973","unstructured":"Distler, A., Just, H.J., Philipp, Th.: Studies on the mechanism of aldosterone-induced hypertension in man. Clin. Sci. Mol. Med.45, 743 (1973)","journal-title":"Clin. Sci. Mol. Med."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(74)90284-0","volume":"2","author":"A.J.M. Donker","year":"1974","unstructured":"Donker, A.J.M., Leenen, F.H.H.: Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension. Lancet2, 1535 (1974)","journal-title":"Lancet"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(76)92222-4","volume":"1","author":"G.G. Geyskes","year":"1976","unstructured":"Geyskes, G.G., Boer, P., Vos, J., Dorhout Mees, E.J.: Renin dependency of blood-pressure. Lancet1, 1049 (1976)","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI108266","volume":"57","author":"N.K. Hollenberg","year":"1976","unstructured":"Hollenberg, N.K., Williams, G.H., Burger, B., Ishikawa, I., Adams, D.F.: Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar-, 8-Ala angiotensin II in normal man. J. clin. Invest.57, 39 (1976)","journal-title":"J. clin. Invest."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0002-8703(62)90197-7","volume":"63","author":"W.P. Johnson","year":"1962","unstructured":"Johnson, W.P., Bruce, R.A.: Hemodynamic and metabolic effects of angiotensin II during rest and exercise in normal healthy subjects. Amer. Heart J.63, 212 (1962)","journal-title":"Amer. Heart J."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2125.1976.tb00625.x","volume":"3","author":"G.A. Mac Gregor","year":"1976","unstructured":"Mac Gregor, G.A., Dawes, P.M.: Agonist and antagonist effects of sar1-ala8-angiotensin II in salt-loaded and salt-depleted normal man. Br. J. clin. Pharmac.3, 483 (1976)","journal-title":"Br. J. clin. Pharmac."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM197503272921301","volume":"292","author":"D.H.P. Streeten","year":"1975","unstructured":"Streeten, D.H.P., Anderson, G.H., Freiberg, J.M., Dalakos, T.G.: Use of an angiotensin II antagonist (saralasin) in the recognition of angiotensinogenic hypertension. New. Engl. J. Med.292, 657 (1975)","journal-title":"New. Engl. J. Med."}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01478829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01478829\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01478829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:32:32Z","timestamp":1556883152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01478829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,9]]},"references-count":8,"journal-issue":{"issue":"18","published-print":{"date-parts":[[1977,9]]}},"alternative-id":["BF01478829"],"URL":"https:\/\/doi.org\/10.1007\/bf01478829","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,9]]}}}